SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Jul-24 5:24 PM View: | Fortrea Holdings Inc. (FTRE) | 18-Jul-24 | Payment of Exercise | 1,907 | $25.85 | $49,295.90 | (30%) 6.35K to 4.45K | |
19-Jul-24 5:24 PM View: | Fortrea Holdings Inc. (FTRE) | 18-Jul-24 | Option Exercise | 6,354 | -- | -- | 100% 0 to 6.35K | |
04-Mar-22 4:13 PM View: | Charles River Laboratories ... (CRL) | 03-Mar-22 | Option Exercise | 8,965 | $136.60 | $1,224,590.00 | 35% 25.82K to 34.78K | (3%) |
04-Mar-22 4:13 PM View: | Charles River Laboratories ... (CRL) | 03-Mar-22 | Private Option Sale | 8,965 | $282.53 | $2,532,920.00 | (26%) 34.78K to 25.82K | |
02-Mar-22 5:33 PM View: | Charles River Laboratories ... (CRL) | 28-Feb-22 | Grant | 5,152 | -- | -- | 25% 20.67K to 25.82K | |
24-Feb-22 6:34 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-22 | Payment of Exercise | 374 | $289.58 | $108,303.00 | (2%) 21.04K to 20.67K | |
24-Feb-22 6:34 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-22 | Payment of Exercise | 341 | $293.61 | $100,121.00 | (2%) 21.38K to 21.04K | |
01-Feb-22 4:47 PM View: | Charles River Laboratories ... (CRL) | 28-Jan-22 | Grant | 12,321 | -- | -- | 85% 14.43K to 26.75K | |
01-Feb-22 4:47 PM View: | Charles River Laboratories ... (CRL) | 28-Jan-22 | Payment of Exercise | 5,364 | $312.24 | $1,674,860.00 | (20%) 26.75K to 21.38K | |
10-Aug-21 11:58 AM View: | Charles River Laboratories ... (CRL) | 09-Aug-21 | Private Sale | 1,750 | $407.40 | $712,954.00 | (11%) 16.18K to 14.43K | |
02-Jun-21 10:27 AM View: | Charles River Laboratories ... (CRL) | 28-May-21 | Grant | 1,313 | -- | -- | 9% 14.86K to 16.18K | |
06-May-21 1:21 PM View: | Charles River Laboratories ... (CRL) | 04-May-21 | Option Exercise | 3,305 | $144.67 | $478,134.00 | 22% 14.86K to 18.17K | (9%) |
06-May-21 1:21 PM View: | Charles River Laboratories ... (CRL) | 04-May-21 | Planned Private Option Sale | 3,305 | $340.01 | $1,123,720.00 | (18%) 18.17K to 14.86K | |
26-Apr-21 1:09 PM View: | Charles River Laboratories ... (CRL) | 22-Apr-21 | Option Exercise | 3,845 | $109.34 | $420,412.00 | 26% 14.86K to 18.71K | |
26-Apr-21 1:09 PM View: | Charles River Laboratories ... (CRL) | 22-Apr-21 | Planned Option Sale | 3,845 | $330.00 | $1,268,850.00 | (21%) 18.71K to 14.86K | |
16-Apr-21 10:00 PM View: | Charles River Laboratories ... (CRL) | 15-Apr-21 | Private Sale (Planned) | 2,000 | $320.00 | $640,000.00 | (12%) 16.86K to 14.86K | |
02-Mar-21 4:39 PM View: | Charles River Laboratories ... (CRL) | 01-Mar-21 | Option Exercise | 4,366 | $88.05 | $384,426.00 | 26% 16.86K to 21.23K | |
02-Mar-21 4:39 PM View: | Charles River Laboratories ... (CRL) | 01-Mar-21 | Option Sale | 4,366 | $290.12 | $1,266,650.00 | (21%) 21.23K to 16.86K | |
25-Feb-21 3:24 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-21 | Payment of Exercise | 289 | $282.98 | $81,781.20 | (2%) 17.15K to 16.86K | |
23-Feb-21 11:16 AM View: | Charles River Laboratories ... (CRL) | 23-Feb-21 | Payment of Exercise | 272 | $283.59 | $77,136.50 | (2%) 17.3K to 17.03K | |
23-Feb-21 11:16 AM View: | Charles River Laboratories ... (CRL) | 22-Feb-21 | Payment of Exercise | 247 | $289.55 | $71,518.80 | (1%) 17.55K to 17.3K | |
23-Feb-21 11:16 AM View: | Charles River Laboratories ... (CRL) | 19-Feb-21 | Private Sale | 8,656 | $290.63 | $2,515,690.00 | (33%) 26.21K to 17.55K | |
02-Feb-21 10:52 AM View: | Charles River Laboratories ... (CRL) | 29-Jan-21 | Grant | 14,234 | -- | -- | 90% 15.77K to 30.0K | |
02-Feb-21 10:52 AM View: | Charles River Laboratories ... (CRL) | 29-Jan-21 | Payment of Exercise | 3,795 | $260.88 | $990,040.00 | (13%) 30.0K to 26.21K | |
02-Feb-21 10:52 AM View: | Charles River Laboratories ... (CRL) | 25-Jan-21 | Gift | 8,656 | -- | -- | 55% 15.77K to 24.42K | |
02-Feb-21 10:52 AM View: | Charles River Laboratories ... (CRL) | 25-Jan-21 | Gift | 8,656 | -- | -- | (35%) 24.42K to 15.77K | |
05-Jan-21 5:21 PM View: | Charles River Laboratories ... (CRL) | 04-Jan-21 | Private Sale (Planned) | 5,000 | $248.76 | $1,243,790.00 | (24%) 20.77K to 15.77K | |
10-Aug-20 4:18 PM View: | Charles River Laboratories ... (CRL) | 07-Aug-20 | Option Exercise | 3,304 | $144.67 | $477,990.00 | 16% 20.77K to 24.07K | (9%) |
10-Aug-20 4:18 PM View: | Charles River Laboratories ... (CRL) | 07-Aug-20 | Private Option Sale | 3,304 | $216.54 | $715,444.00 | (14%) 24.07K to 20.77K | |
02-Jun-20 2:13 PM View: | Charles River Laboratories ... (CRL) | 29-May-20 | Grant | 2,176 | -- | -- | 12% 18.59K to 20.77K | |
08-May-20 10:48 AM View: | Charles River Laboratories ... (CRL) | 07-May-20 | Private Sale (Planned) | 1,884 | $150.00 | $282,600.00 | (9%) 20.48K to 18.59K | |
26-Feb-20 12:20 PM View: | Charles River Laboratories ... (CRL) | 26-Feb-20 | Payment of Exercise | 379 | $162.46 | $61,572.30 | (2%) 20.85K to 20.48K | |
27-Feb-20 2:48 PM View: | Charles River Laboratories ... (CRL) | 26-Feb-20 | Option Exercise | 4,188 | $73.70 | $308,656.00 | 20% 20.48K to 24.66K | |
27-Feb-20 2:48 PM View: | Charles River Laboratories ... (CRL) | 26-Feb-20 | Planned Option Sale | 4,188 | $162.26 | $679,535.00 | (17%) 24.66K to 20.48K | |
24-Feb-20 12:33 PM View: | Charles River Laboratories ... (CRL) | 24-Feb-20 | Payment of Exercise | 402 | $173.64 | $69,803.30 | (2%) 21.26K to 20.85K | |
25-Feb-20 11:29 AM View: | Charles River Laboratories ... (CRL) | 24-Feb-20 | Option Exercise | 8,211 | $98.02 | $804,860.00 | 39% 20.85K to 29.07K | |
25-Feb-20 11:29 AM View: | Charles River Laboratories ... (CRL) | 24-Feb-20 | Planned Option Sale | 8,211 | $166.72 | $1,368,950.00 | (28%) 29.07K to 20.85K | |
24-Feb-20 12:33 PM View: | Charles River Laboratories ... (CRL) | 23-Feb-20 | Payment of Exercise | 378 | $173.64 | $65,635.90 | (2%) 21.63K to 21.26K | |
24-Feb-20 12:33 PM View: | Charles River Laboratories ... (CRL) | 22-Feb-20 | Payment of Exercise | 344 | $173.64 | $59,732.20 | (2%) 21.98K to 21.63K | |
13-Feb-20 7:08 PM View: | Charles River Laboratories ... (CRL) | 13-Feb-20 | Private Sale | 4,500 | $170.29 | $766,318.00 | (17%) 26.48K to 21.98K | |
10-Feb-20 3:49 PM View: | Charles River Laboratories ... (CRL) | 07-Feb-20 | Grant | 13,431 | -- | -- | 74% 18.08K to 31.51K | |
10-Feb-20 3:49 PM View: | Charles River Laboratories ... (CRL) | 07-Feb-20 | Payment of Exercise | 5,031 | $159.07 | $800,281.00 | (16%) 31.51K to 26.48K | |
12-Aug-19 3:25 PM View: | Charles River Laboratories ... (CRL) | 12-Aug-19 | Payment of Exercise | 337 | $132.60 | $44,686.20 | (2%) 18.41K to 18.08K | < 1% |
13-Aug-19 3:32 PM View: | Charles River Laboratories ... (CRL) | 12-Aug-19 | Option Exercise | 1,249 | $76.12 | $95,073.90 | 7% 18.08K to 19.33K | |
13-Aug-19 3:32 PM View: | Charles River Laboratories ... (CRL) | 12-Aug-19 | Option Sale | 1,249 | $130.36 | $162,821.00 | (6%) 19.33K to 18.08K | |
28-Feb-19 9:23 AM View: | Charles River Laboratories ... (CRL) | 27-Feb-19 | Payment of Exercise | 218 | $140.57 | $30,644.30 | (1%) 18.63K to 18.41K | (1%) |
01-Mar-19 11:42 AM View: | Charles River Laboratories ... (CRL) | 27-Feb-19 | Option Exercise | 2,158 | $76.67 | $165,454.00 | 12% 18.41K to 20.57K | |
01-Mar-19 11:42 AM View: | Charles River Laboratories ... (CRL) | 27-Feb-19 | Market Option Sale (Planned) | 2,158 | $141.07 | $304,435.00 | (10%) 20.57K to 18.41K | |
26-Feb-19 10:00 PM View: | Charles River Laboratories ... (CRL) | 26-Feb-19 | Payment of Exercise | 379 | $145.31 | $55,072.50 | (2%) 20.46K to 20.08K | 3% |
28-Feb-19 9:21 AM View: | Charles River Laboratories ... (CRL) | 26-Feb-19 | Option Exercise | 4,187 | $73.70 | $308,582.00 | 21% 20.08K to 24.27K |